ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,398 | -35.1% | 14,776 | 0.0% | 0.00% | – |
Q1 2023 | $5,237 | -2.7% | 14,776 | -11.9% | 0.00% | – |
Q4 2022 | $5,383 | -55.1% | 16,776 | 0.0% | 0.00% | – |
Q3 2022 | $12,000 | -20.0% | 16,776 | 0.0% | 0.00% | – |
Q2 2022 | $15,000 | -40.0% | 16,776 | 0.0% | 0.00% | – |
Q1 2022 | $25,000 | -55.4% | 16,776 | +6.5% | 0.00% | – |
Q3 2021 | $56,000 | – | 15,749 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |